"I watched his countenance closely, to see if he was not deranged ... and I was assured by other senators after he left the room that they had no confidence in it."
U.S. Senator Smith of Indiana ; After seeing Samuel Morse demonstrate the telegraph.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7964181 | Amino acid surrogates for peptidic constructs Ring-constrained amino acid surrogates of formula I: where R1, R2, R3, R4, R5, R6a, R6b, R7, and y are as defined in the specification,... | 06/21/2011 |
| 7238348 | Method of treatment of osteoporosis with compositions of red rice fermentation products Methods are disclosed for using red rice fermentation products for the treatment or prevention of osteoporosis and abnormal bone mass conditions. Particular Monascus strains yield fermentation products with the desired biological activities. ... | 07/03/2007 |
| 7175856 | Palatable oral suspension and method A drug formulation in the form of a dry powder is provided which when mixed with water forms a palatable oral suspension substantially free of bitter taste, the dry powder being formed of a drug, preferably des-quinolone, which in solution has a bitter taste, and a ... | 02/13/2007 |
| 7138122 | Therapeutic systems A compound comprising a target cell-specific portion and human NAD(P)H:quinone reductase 2 (NQO2) or a variant or fragment or fusion or derivative thereof which has substantially the same activity as NQO2 towards a given prodrug, or a polynucleotide encoding said NQ... | 11/21/2006 |
| 7087223 | Preventives and/or remedies for hyperphosphatemia Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect... | 08/08/2006 |
| 6867231 | Therapeutic systems A compound comprising a target cell-specific portion and human NAD(P)H:quinone reductase 2 (NQO2) or a variant or fragment or fusion or derivative thereof which has substantially the same activity as NQO2 towards a given prodrug, or a polynucleotide encoding said NQ... | 03/15/2005 |
| 6844372 | Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same An cross-linked anion exchange resin or a salt thereof obtained by reacting a polymer (A) having amino and/or imino groups in the total number of two or more per molecule with a compound (B) having two or more functional groups capable of reacting with amino and/or ... | 01/18/2005 |
| 6692732 | Ionic polymers as toxin-binding agents A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c... | 02/17/2004 |
| 6610284 | Preparation for prevention and healing of inflammation affections A preparation for prevention and healing of inflammation affections comprising in an amount of 0.1 to 99.9% by weight derivatives of sterically hindered amines selected from the group consisting of: soluble polymers or copolymers prepared by radical polym... | 08/26/2003 |
| 6514492 | Taste masking of oral quinolone liquid preparations using ion exchange resins This invention relates to the formulation of oral liquid products of quinolones or derivatives thereof using ion exchange resins, such as methacrylic acid polymer crosslinked with divinylbenzene, as the carrier, thereby eliminating the extreme bitterness ... | 02/04/2003 |
| 6290947 | Ionic polymers as toxin-binding agents A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c... | 09/18/2001 |
| 6084005 | Antimicrobial caries-detecting composition An antimicrobial caries-detecting composition, which comprises(i) water, a water-miscible solvent or a combination thereof, (ii) a dye capable of staining the caries-infected portions of teeth, and (iii) at least one antimicrobial agent.... | 07/04/2000 |
| 6007803 | Ionic polymers as toxin binding agents A method for treating pathogenic toxins in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising a cationic group attached to the polymer backbone. The polymer can be a homopolymer or a c... | 12/28/1999 |
| 5935604 | Nasal drug delivery composition containing nicotine The present invention provides a nasal drug delivery composition comprising nicotine or a pharmacologically-acceptable salt or derivative thereof wherein the composition is adapted to delivery a pulse of nicotine for rapid absorption and a controlled rele... | 08/10/1999 |
| 5888526 | Antibacterial antifungal agent and fibrous material containing the same The present invention is to provide a fibrous material containing an antibacterial antifungal agent consisting of specific metal salt of organic compound effective for both antibacterial and antifungal functions and various articles containing the same fi... | 03/30/1999 |
| 5874522 | Crosslinked polymeric ammonium salts Disclosed are novel crosslinked polymeric ammonium salts wherein in said polymeric salt: about 25% or more of the segments which link ammonium nitrogen atoms are group Y wherein Y is an n-alkylene group or alkyl substituted n-alkylene group, wherein said ... | 02/23/1999 |
| 5861437 | Polyphenylene ether resin A poly(phenylene ether) resin composed of structural units represented by the general formula: ##STR1## (wherein R1, R2 and R3 represent each alkyl, cycloalkyl, etc. or H (provided that two or more of R1, R... | 01/19/1999 |
| 5726284 | Crosslinked polymric ammonium salts Disclosed are novel crosslinked polymeric ammonium salts wherein in said polymeric salt: about 25% or more of the segments which link ammonium nitrogen atoms are group Y wherein Y is an n-alkylene group or alkyl substituted n-alkylene group, wherein said ... | 03/10/1998 |
| 5575993 | Ionene polymers containing biologically-active anions Ionene polymers having biologically-active organic and/or inorganic anions are described. Methods to prepare the ionene polymers, compositions containing them and their methods of use are also described.... | 11/19/1996 |
| 5516881 | Aminoxyl-containing radical spin labeling in polymers and copolymers Aminoxyl-containing radical is provided in polymers and copolymers by replacing a hydroxyl moiety in a carboxyl group at a chain end of a starting material biodegradable polymer or copolymer with imino or oxy linked to aminoxyl-containing radical to form ... | 05/14/1996 |
| 5505952 | Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom Synthetic, cross-linked amino-acid containing polymers are useful in forming medical devices. The hydrogels of the invention are particularly useful in wound healing and anti-adhesion applications.... | 04/09/1996 |
| 5498409 | Material for adsorbing pyrogen An insoluble material for adsorbing a pyrogen comprising a polymer of an aziridine compound. According to the present invention, a large amount of the pyrogen can be easily removed from a solution containing pyrogen, and a large amount of the material for... | 03/12/1996 |
| 5496819 | Antiphlogistic-analgesic plaster comprising triacetin and piroxicam An antiphlogistic-analgesic plaster comprising piroxicam and triacetin and/or triethyl citrate. The antiphlogistic-analgesic plaster of the invention is excellent in percutaneous absorption of piroxicam and hence has an excellent antiphlogistic and analge... | 03/05/1996 |
| 5460807 | Antiproliferative oligomers The oligomers of the present invention are polyureas or polyamides having a number average molecular weight of | 10/24/1995 |
| 5447726 | Orally administrable cholesterol lowering agent There is provided an orally administrable cholesterol lowering agent which is obtained by coating with hydroxypropylmethylcellulose plain tablets containing an anion exchange resin as an active component and containing 14-20% by weight of water and not mo... | 09/05/1995 |
| 5401499 | Method of adsorbing pyrogens An insoluble material for adsorbing a pyrogen comprising a polymer of an aziridine compound. According to the present invention, a large mount of the pyrogen can be easily removed from a solution containing pyrogen, and a large amount of the material for ... | 03/28/1995 |
| 5246698 | Biocompatible viscoelastic gel slurries, their preparation and use Disclosed are biocompatible viscoelastic gel slurries formed from a polymeric gel, preferably a hyaluronan or a derivative thereof such as hylan swollen in an aqueous medium and a fluid phase which is an aqueous solution of a polymer which may also but no... | 09/21/1993 |
| 5209922 | Water soluble polymers having antifungal properties This invention relates to an antifungal block copolymer of poly(vinyl lactam) having the formula ##STR1## where m has a value of from 1 to 3 and from about 15 to about 25 wt. % of a quaternized amino alkyl acrylamide comonomer wherein the quaternizin... | 05/11/1993 |
| 5152986 | Preparation and use of ion exchange resins loaded with quinolonecarboxylic acid derivatives Known antibacterial quinolonecarboxylic acid derivatives such as ciprofloxacin are administered to animals in their food in the form of weak cation exchangers loaded therewith. The taste is much improved and the animals accept the material more readily.... | 10/06/1992 |
| 5143724 | Biocompatible viscoelastic gel slurries, their preparation and use Disclosed are biocompatible viscoelastic gel slurries formed from a polymeric gel, preferably a hyaluronan or a derivative thereof such as hylan swollen in an aqueous medium and a fluid phase which is an aqueous solution of a polymer which may also but no... | 09/01/1992 |
| 4996047 | Sustained release drug-resin complexes Disclosed are oral pharmaceutical preparations which comprise a pharmacologically active drug bound to small particles of an ion-exchange resin to provide a drug-resin complex having a drug content above a specified value. The drug-resin complex is subseq... | 02/26/1991 |
| 4843130 | Antibacterial polymer An antibacterial polymer containing a repeating unit of the formula ##STR1## wherein A, l and n are defined in the specification.... | 06/27/1989 |
| 4788055 | Resinate sustained release dextromethorphan composition A pharmaceutical preparation for controlled, sustained release of dextromethorphan comprising a polystyrene sulfonate resin which has been cross-linked with about 3% to about 10% divinyl benzene, having an average particle size of at least 48 μm and less... | 11/29/1988 |
| 4780322 | Method of producing slow-release pharmaceutical forms The invention relates to a novel method of producing slow-release pharmaceutical forms administered per os, by simultaneously employing two resins having anionic character, the proportions of said resins being variable. By varying the ratio of the amounts... | 10/25/1988 |
| 4578268 | Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals There are provided palatable anthelmintic resinate compositions for companion animals, containing anthelmintically effective amounts of a styrylpyridinium compound and/or an N,N-dialkylpiperazine carboxamide.... | 03/25/1986 |